DTIL compared with CUE: revenue, margins and what each company keeps, and the suppliers and customers both name

DTILPrecision Biosciences Inc

Mkt capRevenueRevenue

CUECue Biopharma, Inc.

Mkt capRevenueRevenue

Compare

DTILPrecision Biosciences Inc

CUECue Biopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

DTIL, solidCUE, dashed

Supply-chain overlap

Revenue flow

DTIL: latest quarter is a loss; flow not drawable. CUE: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DTIL 12

TGTXTG Therapeuticscustomer

MXCTMaxcytesupplier

—Cellectisunlistedsupplier

—Duke Universityunlistedsupplier

8 more · DTIL chain ›

Shared 0

No shared counterparties.

Only CUE 3

—Boehringer Ingelheimunlistedcustomer

—ImmunoScapeunlistedcustomer

—LG Chemunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

DTILPrecision Biosciences Inc

7.07▼−5.03%· post 7.07

Mkt cap$194.9MRevenue$11MQ1 FY26Revenue$34MFY25

CUECue Biopharma, Inc.

20.53▼−4.31%· post 20.53

ClosedOct 30 '26

Mkt cap$151.6MRevenue$8MQ2 FY26Revenue$27MFY25

Compare

ClosedOct 30 '26

DTILPrecision Biosciences Inc

CUECue Biopharma, Inc.

7.07▼−5.03%post 7.07

Price

20.53▼−4.31%post 20.53

$194.9M

Mkt cap

$151.6M

Q1 FY26$11M

Revenue

$8MQ2 FY26

FY25$34M

Revenue

$27MFY25

DTIL7.07▼−5.03%vsCUE20.53▼−4.31%ClosedOct 30 '26